Clinical trial
Ixekizumab in the Treatment of Pityriasis Rubra Pilaris (PRP)
NCT03485976 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ixekizumab in the Treatment of Pityriasis Rubra Pilaris (PRP)
- Lead sponsor
- Oregon Health and Science University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 23, 2018
- Completion date
- January 13, 2020
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.